Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells
- PMID: 15959515
- DOI: 10.1038/nature03659
Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells
Abstract
The self-renewing epithelium of the small intestine is ordered into stem/progenitor crypt compartments and differentiated villus compartments. Recent evidence indicates that the Wnt cascade is the dominant force in controlling cell fate along the crypt-villus axis. Here we show a rapid, massive conversion of proliferative crypt cells into post-mitotic goblet cells after conditional removal of the common Notch pathway transcription factor CSL/RBP-J. We obtained a similar phenotype by blocking the Notch cascade with a gamma-secretase inhibitor. The inhibitor also induced goblet cell differentiation in adenomas in mice carrying a mutation of the Apc tumour suppressor gene. Thus, maintenance of undifferentiated, proliferative cells in crypts and adenomas requires the concerted activation of the Notch and Wnt cascades. Our data indicate that gamma-secretase inhibitors, developed for Alzheimer's disease, might be of therapeutic benefit in colorectal neoplastic disease.
Similar articles
-
Conversion of metaplastic Barrett's epithelium into post-mitotic goblet cells by gamma-secretase inhibition.Dis Model Mech. 2010 Jan-Feb;3(1-2):104-10. doi: 10.1242/dmm.003012. Dis Model Mech. 2010. PMID: 20075383
-
Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation.Toxicol Sci. 2004 Nov;82(1):341-58. doi: 10.1093/toxsci/kfh254. Epub 2004 Aug 19. Toxicol Sci. 2004. PMID: 15319485
-
Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.Cancer Res. 2006 Aug 1;66(15):7445-52. doi: 10.1158/0008-5472.CAN-06-0858. Cancer Res. 2006. PMID: 16885340
-
Wnt control of stem cells and differentiation in the intestinal epithelium.Exp Cell Res. 2005 Jun 10;306(2):357-63. doi: 10.1016/j.yexcr.2005.02.022. Epub 2005 Apr 7. Exp Cell Res. 2005. PMID: 15925592 Review.
-
Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease.Trends Mol Med. 2005 Nov;11(11):496-502. doi: 10.1016/j.molmed.2005.09.008. Epub 2005 Oct 7. Trends Mol Med. 2005. PMID: 16214417 Review.
Cited by
-
Cooperation of Wnt/β-catenin and Dll1-mediated Notch pathway in Lgr5-positive intestinal stem cells regulates the mucosal injury and repair in DSS-induced colitis mice model.Gastroenterol Rep (Oxf). 2024 Oct 23;12:goae090. doi: 10.1093/gastro/goae090. eCollection 2024. Gastroenterol Rep (Oxf). 2024. PMID: 39444950 Free PMC article.
-
Alzheimer's disease: presenilin 2-sparing γ-secretase inhibition is a tolerable Aβ peptide-lowering strategy.J Neurosci. 2012 Nov 28;32(48):17297-305. doi: 10.1523/JNEUROSCI.1451-12.2012. J Neurosci. 2012. PMID: 23197721 Free PMC article.
-
A reaction-diffusion mechanism influences cell lineage progression as a basis for formation, regeneration, and stability of intestinal crypts.BMC Syst Biol. 2012 Jul 31;6:93. doi: 10.1186/1752-0509-6-93. BMC Syst Biol. 2012. PMID: 22849824 Free PMC article.
-
Notch signaling in pancreatic cancer: oncogene or tumor suppressor?Trends Mol Med. 2013 May;19(5):320-7. doi: 10.1016/j.molmed.2013.03.003. Epub 2013 Mar 29. Trends Mol Med. 2013. PMID: 23545339 Free PMC article. Review.
-
Asymmetric division: An antitumor player?Mol Cell Oncol. 2016 May 19;3(4):e1164279. doi: 10.1080/23723556.2016.1164279. eCollection 2016 Jul. Mol Cell Oncol. 2016. PMID: 27652318 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases